Skip to Main Content

Paper Details

Cerdulatinib, a novel dual SYK/JAK kinase inhibitor, has broad anti-tumor activity in both ABC and GCB types of diffuse large B cell lymphoma.
Oncotarget
39
2015
Author NameAffiliation
Gordana RacaUniversity of Chicago
  • 1 - 1

Datasets

Release 1.2